Mary-Claire King to receive the 2006 Weizmann Women & Science Award

May 23, 2006

The American Committee for the Weizmann Institute of Science has announced that Mary-Claire King, Ph.D., who is internationally known for her contributions to the field of genetics, will receive the 2006 Weizmann Women & Science Award. The Award will be presented by journalist Lesley Stahl, correspondent for the CBS program 60 Minutes, at a ceremony at Rockefeller University on June 12.

"Prof. King's career demonstrates originality, dedication, and innovation," said Sara Lee Schupf, Chair of the nominating committee and initiator of the Award. "Widely respected within the scientific community, her monumental accomplishments have the potential to improve the quality of life for millions. She embodies the spirit of the Weizmann Women & Science Award, and is a superb role model for young women."

Prof. King is the American Cancer Society Research Professor of Medicine and Genome Sciences at the University of Washington in Seattle. Her primary research focus is the characterization of inherited breast cancer, and she was the first to prove that breast cancer is inherited in some families. Her major findings include the discovery of the BRCA 1 gene that predisposes individuals to this widespread disease, which kills 40,000 women annually in the U.S. Prof. King's other interests include inherited deafness, systemic lupus erythematosus, human genetic diversity and evolution, and the application of genomics to human rights problems. Her laboratory has carried out DNA identifications for the War Crimes Tribunal of the United Nations. She has been recognized with many prestigious honors, such as the Clowes Award in Basic Research from the American Association of Cancer Research, the Jill Rose Award from the American Breast Cancer Foundation, and the Brinker Award from the Susan G. Komen Foundation. Prof. King has served on many councils and committees related to women's health and public policy.

The Weizmann Institute in Rehovot, Israel, is a world-renowned center for science and technology research; for over sixty years, the American Committee has been a major source of its support. The Weizmann Women & Science Award, which is given out biennially and includes a research grant, was established in 1994 under the guidance of Sara Lee Schupf, who was then Chair of the American Committee. It honors an outstanding woman scientist in the U.S. who has made a major contribution to science, technology, or engineering, and seeks to encourage the next generation of women scientists. Past winners are Joan Argetsinger Steitz (biophysics), Vera Rubin (astronomy), Jacqueline K. Barton (chemistry), Carla J. Shatz (neurobiology), Susan Solomon (aeronomy), and May Berenbaum (entomology).

Ms. Schupf conceived of the Award to address what she saw as an overwhelming lack of support for women in an important, male-dominated field. One of the first awards of its kind, it has grown in prominence over the last twelve years and become a model for other organizations. "The Weizmann Women & Science Award has shined a spotlight on the extraordinary achievements of our nation's finest women scientists," said Ms. Schupf. "In doing so, it has emphasized the need to inspire young women to pursue scientific careers, and I am pleased to see that this issue is now becoming an item of focus on the national agenda."

The Award ceremony on June 12 will also include remarks from the Weizmann Institute's Prof. Ruth Arnon, a world-renowned immunologist. More information about the event can be obtained by contacting Merritt Birnbaum at (212) 895-7908 or merritt@acwis.org.
-end-
The American Committee for the Weizmann Institute of Science (ACWIS), founded in 1944, develops philanthropic support for the Weizmann Institute of Science in Rehovot, Israel, one of the world's premier scientific research institutions. The Weizmann Institute is a center of multidisciplinary scientific research and graduate study, addressing crucial problems in medicine and health, technology, energy, agriculture, and the environment. For additional information, please visit www.weizmann-usa.org.

American Committee for the Weizmann Institute of Science

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.